CBT
WST icon

Capital Bank & Trust’s West Pharmaceutical WST Stock Holding History

Capital Bank & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-48
Closed -$5K – 744
2019
Q1 		$5K Sell
48
-424
-90% -$44.1K ﹤0.01% 605
2018
Q4 		$46K Buy
472
+260
+123% +$28.2K ﹤0.01% 430
2018
Q3 		$26K Buy
+212
New +$23.8K ﹤0.01% 555

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital Bank & Trust's WST Position: Q2 2019 in Review

Capital Bank & Trust sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 48 shares — an estimated $5K sold.

Capital Bank & Trust first reported a position in WST in Q3 2018 and held it in 3 quarters. The position peaked at $46K in Q4 2018. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

  • Capital Bank & Trust reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 48 West Pharmaceutical shares in Q2 2019, an estimated $5K.
  • Capital Bank & Trust first reported a position in West Pharmaceutical in Q3 2018 and held it in 3 quarters.
  • Capital Bank & Trust's West Pharmaceutical position peaked at $46K in Q4 2018.
  • 374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on Capital Bank & Trust's 13F filing for Q2 2019, filed 14 Aug 2019.